Recent Advancements of Macrolide Hybrids Against Staphylococcus Aureus

(E-pub Ahead of Print)

Author(s): Chaofan Ji, Xiaozhou Xu*

Journal Name: Current Topics in Medicinal Chemistry

Become EABM
Become Reviewer
Call for Editor


Staphylococcus aureus (S. aureus), recognized as one of the deadliest pathogens responsible for nosocomial and community acquired infections, is highly contagious and associated with significant morbidity and mortality. The increasing emergency and rapid spread of various forms of drug-resistant S. aureus have already posed heavy burden on world health system, but new-fangled antibiotics are right now being created at a much slower pace than our developing requirement. Macrolides could inhibit protein synthesis by targeting the bacterial ribosome and are a class of basic and widely used antibacterial agents in clinical practice to control infections caused by various bacteria including S. aureus. However, emer-gence of bacterial resistance to macrolide antibiotics, particularly in Gram-positive bacteria such as macrolide-resistant S. aureus, has already become one of the significant obstacles for effective chemotherapy. Therefore, there is a critical need for the development of novel macrolide candidates. This review provides an overview of macrolide hybrids with potential activity against S. aureus including drug-resistant forms developed in recent decade, with special emphasis on the structure-activity relationships and mechanism of actions.

Keywords: Antibacterial, hybrids, macrolide, methicillin-resistant Staphylococcus aureus, Staphylococcus aureus

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1568026620999201203213733
Price: $95

Article Metrics

PDF: 4